Davenport & CO LLC Mustang Bio, Inc. Transaction History

Davenport & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$0.32 - $8.27 $1,600 - $41,350	-5,000 Reduced 14.16%	30,300 $0
Q2 2022 Jul 18, 2022	SELL	$0.58 - $1.13 $1,566 - $3,050	-2,700 Reduced 7.11%	35,300 $21,000
Q4 2021 Feb 10, 2022	SELL	$1.66 - $2.64 $52,539 - $83,556	-31,650 Reduced 45.44%	38,000 $63,000
Q3 2021 Oct 14, 2021	SELL	$2.58 - $3.36 $903 - $1,176	-350 Reduced 0.5%	69,650 $187,000
Q4 2020 Jan 13, 2021	BUY	$2.66 - $4.18 $11,970 - $18,810	4,500 Added 6.87%	70,000 $265,000
Q3 2020 Oct 15, 2020	SELL	$3.01 - $3.88 $30,099 - $38,800	-10,000 Reduced 13.25%	65,500 $206,000
Q1 2020 May 05, 2020	BUY	$1.91 - $4.52 $144,205 - $341,259	75,500 New	75,500 $202,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.